TeSR™-AOF Data Overview
Hear directly from the creator of TeSR™-AOF, STEMCELL Scientist Kim Snyder, as she explains the rationale behind TeSR™-AOF and gives a detailed overview of some preliminary data in this talk from the Till & McCulloch Meetings 2020.
Publish Date:
January 18, 2021
Related Multimedia
-
Nature Research Round Table: Retinal Cell Therapy Using Human Embryonic Stem Cells
Publish Date: November 01, 2019 -
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019 -
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
Publish Date: June 09, 2020
Explore Our Products
-
cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent -
Defined, xeno-free matrix that supports the growth and differentiation of human pluripotent stem cells under serum-free, feeder-free conditions -
cGMP, animal origin-free, stabilized, feeder-free maintenance medium for human ES and iPS cells
